SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
HERREGRAVEN MARC

(Last) (First) (Middle)
1757 SNELLING AVE

(Street)
FALCON HEIGHTS MN 55113

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
UROPLASTY INC [ UPI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
VP Manufacturing
3. Date of Earliest Transaction (Month/Day/Year)
06/08/2007
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
common stock 06/08/2007 06/08/2007 U 20,000 D $3.4071 73,333(1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
stock options $1.1 06/08/2007 06/08/2007 X 4,000 09/04/2002 09/04/2007 common stock 4,000 (2) 79,333 D
stock options $1.1 06/08/2007 06/08/2007 X 4,000 09/04/2003 09/04/2007 common stock 4,000 (2) 75,333 D
stock options $1.1 06/08/2007 06/08/2007 X 4,000 09/04/2004 09/04/2007 common stock 4,000 (2) 71,333 D
stock options $1.1 06/08/2007 06/08/2007 X 4,000 09/04/2005 09/04/2007 common stock 4,000 (2) 67,333 D
stock options $1.1 06/08/2007 06/08/2007 X 4,000 09/04/2006 09/04/2007 common stock 4,000 (2) 63,333(3) D
Explanation of Responses:
1. Includes 10,000 shares and 63,333 shares that Mr. Herregraven may acquire upon the exercise of options that are exercisable within 60 days of June 8, 2007.
2. The price is not applicable as this is not the sale of a derivative security but rather the exercise of a derivative security.
3. Includes 63,333 shares that Mr. Herregraven may acquire upon the exercise of options that are exercisable within 60 days of June 8, 2007.
Remarks:
Signature is on behalf of Marc Herregraven
Larry Bakeman 06/12/2007
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.